Induction of response and remission: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis

被引:0
|
作者
Vickers, A. [1 ]
Nag, A. [2 ]
Devine, B. [3 ]
Sands, B. E. [4 ]
Panaccione, R. [5 ]
Peyrin-Biroulet, L. [6 ]
Danese, S. [7 ]
Vermeire, S. [8 ]
Gorelick, K. J. [9 ]
Goetsch, M. [10 ]
Hartley, L. [1 ]
机构
[1] RTI Hlth Solut, Data Analyt & Design Strategy, Manchester, Lancs, England
[2] Shire, Outcomes Res & Epidemiol, Lexington, MA USA
[3] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
[4] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, Med Ctr, New York, NY 10029 USA
[5] Univ Calgary, Div Gastroenterol, Calgary, AB, Canada
[6] Univ Hosp Nancy Brabois, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[7] Humanitas Univ, IBD Ctr, Milan, Italy
[8] Univ Hosp Leuven, Dept Gastroenterol, Leuven, Belgium
[9] Zymo Consulting Grp, Clin Dev, Newtown Sq, PA USA
[10] Shire, Zug, Switzerland
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P341
引用
收藏
页码:S327 / S328
页数:2
相关论文
共 50 条
  • [21] Ozanimod for induction treatment of Moderate-to-Severe Ulcerative Colitis: Results from a systematic literature review and network meta-analyses
    Eaton, K.
    Duperrouzel, C.
    Bhandari, P.
    Bonner, A.
    Cameron, C.
    Tencer, T.
    Kumar, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S103 - S104
  • [22] Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis
    Bonovas, S.
    Lytras, T.
    Nikolopoulos, G.
    Peyrin-Biroulet, L.
    Danese, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (04) : 454 - 465
  • [23] Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis (vol 15, pg 551, 2021)
    Vermeire, Severine
    Lukas, Milan
    Magro, Fernando
    Adsul, Shashi
    Lindner, Dirk
    Rosario, Maria
    Roth, Jeannine
    Danese, Silvio
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (04): : 696 - 696
  • [24] Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Hibi, Toshifumi
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 85 - 95
  • [25] Comparison of Mesalazine and Balsalazide in Induction and Maintenance of Remission in Patients with Ulcerative Colitis: A Meta-Analysis
    Roja Rahimi
    Shekoufeh Nikfar
    Ali Rezaie
    Mohammad Abdollahi
    Digestive Diseases and Sciences, 2009, 54 : 712 - 721
  • [26] Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis: A meta-analysis
    Qiu, Yun
    Chen, Humin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 798 - 799
  • [27] Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis
    Mosli, Mahmoud H.
    MacDonald, John K.
    Bickston, Stephen J.
    Behm, Brian W.
    Tsoulis, David J.
    Cheng, Jianfeng
    Khanna, Reena
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (05) : 1151 - 1159
  • [28] Comparison of Mesalazine and Balsalazide in Induction and Maintenance of Remission in Patients with Ulcerative Colitis: A Meta-Analysis
    Rahimi, Roja
    Nikfar, Shekoufeh
    Rezaie, Ali
    Abdollahi, Mohammad
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (04) : 712 - 721
  • [29] Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-Analysis
    Harper, Julie C.
    Baldwin, Hilary
    Choudhury, Saswata Paul
    Rai, Deepti
    Ghosh, Bikramaditya
    Aman, Md Sohail
    Choudhury, Abhra R.
    Dutta, Sekhar Kumar
    Dey, Debalina
    Bhattacharyya, Subrata
    Lin, Tina
    Joseph, George
    Dashputre, Ankur A.
    Tan, Jerry K. L.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (04) : 216 - 226
  • [30] Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
    Midha, Vandana
    Mahajan, Ramit
    Mehta, Varun
    Narang, Vikram
    Singh, Arshdeep
    Kaur, Kirandeep
    Sood, Ajit
    INTESTINAL RESEARCH, 2018, 16 (01) : 83 - 89